Healthcare Services

Lung Cancer Screening Market Insights Exploring Expansion Opportunities Through 2030

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Forecasted Market Size Figures For The Lung Cancer Screening Market In 2026 And 2030?

The lung cancer screening market has demonstrated robust expansion recently. Forecasts indicate its size will increase from $3.33 billion in 2025 to $3.65 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.6%. This historical growth is linked to factors such as a greater occurrence of lung cancer among older demographics, heightened understanding of the advantages of early detection, the development of diagnostic imaging facilities, advancements in CT imaging technology, and the implementation of screening protocols based on established guidelines.

The lung cancer screening market is anticipated to experience substantial expansion in the coming years, projected to reach $5.24 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This growth during the forecast period is primarily driven by the rising implementation of AI-assisted diagnostic workflows, the broadening of population-based screening initiatives, an intensified focus on personalized risk assessment, escalating investments in technologies for early cancer detection, and greater healthcare policy endorsement for screening. Additionally, key trends anticipated for this period encompass the increasing uptake of low-dose CT screening programs, the growing incorporation of AI into imaging analysis, a sharpened focus on screening high-risk populations, the broadening of preventive oncology initiatives, and an elevated emphasis on the early detection of lung cancer.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27331&type=smp

Which Growth Drivers Are Expected To Support The Lung Cancer Screening Market Forward?

The projected increase in smoking rates is set to boost the expansion of the lung cancer screening market moving forward. Smoking is defined as the act of breathing in smoke from burning substances, most often tobacco, through the mouth and into the lungs. The surge in smoking rates is attributed to elevated stress levels, which cause more individuals to resort to smoking as a coping mechanism. Lung cancer screening plays a crucial role in addressing rising smoking rates by facilitating the early detection of health risks associated with smoking, thus motivating individuals to quit and contributing to broader public health endeavors aimed at reducing tobacco use. For instance, in October 2024, the Office for Health Improvement & Disparities, a UK-based government organisation, reported that the prevalence of current smokers within the routine and manual occupation group (aged 18 to 64) in 2023 was 19.5%. Therefore, the growing smoking rates are propelling the growth of the lung cancer screening market.

Which Segment-Based Categories Are Covered In The Lung Cancer Screening Market?

The lung cancer screening market covered in this report is segmented –

1) By Diagnosis Type: Low Dose Spiral Computed Tomography Scan, Chest-X-Ray

2) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer

3) By Age Group: 50 And Older, Below 50

4) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Low Dose Spiral Computed Tomography Scan: Screening, Diagnostic, Follow-Up

2) By Chest X-Ray: Posterior Anterior, Lateral, Portable

Which Trends Are Contributing To Changes In The Lung Cancer Screening Market?

Major companies operating in the lung cancer screening market are concentrating on developing advanced solutions, such as normal flagging, to enhance diagnostic precision, reduce false positives, and improve the early identification of cancerous nodules. Normal flagging refers to a technological feature in lung cancer screening that automatically identifies and marks scans without abnormal findings, assisting in prioritizing cases that require further review. For instance, in May 2025, Lunit Inc., a South Korea-based medical technology company, unveiled INSIGHT CXR4, its next-generation artificial intelligence (AI)-powered chest X-ray analysis solution, which is now CE MDR-certified for deployment across Europe. Engineered to aid radiologists with improved diagnostic accuracy and workflow efficiency, the solution identifies 12 chest abnormalities, including lung nodules, pneumonia, and acute bone fractures, and integrates features like current-prior image comparison to support early disease detection and clinical decision-making.

Which Organizations Are Involved In The Lung Cancer Screening Market?

Major companies operating in the lung cancer screening market are Abbott Laboratories Inc., Canon Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Quest Diagnostics Incorporated, Shimadzu Corporation, NeoGenomics Laboratories Inc., Freenome Holdings Inc., Biodesix Inc., Lunit Inc., Infervision, Riverain Technologies, VisionGate, Delfi Diagnostics Inc., Hologic Inc., Fujifilm Holdings Corporation, United Imaging Healthcare Co. Ltd., Samsung Medison Co. Ltd., Carestream Health Inc., Analogic Corporation, Toshiba Medical Systems Corporation

Access The Complete Lung Cancer Screening Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-screening-global-market-report

Which Region Is The Dominant Market In The Lung Cancer Screening Market?

North America was the largest region in the lung cancer screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Lung Cancer Screening Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=27331&type=smp

Browse Through More Reports Similar to the Global Lung Cancer Screening Market 2026, By The Business Research Company

Financial Fraud Detection Software Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/financial-fraud-detection-software-global-market-report

Payment Monitoring Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/payment-monitoring-global-market-report

Ecommerce Fraud Detection And Prevention Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ecommerce-fraud-detection-and-prevention-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795